Comparative analysis of CI- and CIV-containing respiratory supercomplexes at single-cell resolution.

brain in-situ imaging analysis mitochondria mitochondrial diseases mitochondrial dysfunction mitochondrial respiratory supercomplexes proximity ligation assay

Journal

Cell reports methods
ISSN: 2667-2375
Titre abrégé: Cell Rep Methods
Pays: United States
ID NLM: 9918227360606676

Informations de publication

Date de publication:
24 05 2021
Historique:
received: 28 09 2020
revised: 03 02 2021
accepted: 03 03 2021
entrez: 27 4 2022
pubmed: 28 4 2022
medline: 28 4 2022
Statut: epublish

Résumé

Mitochondria sustain the energy demand of the cell. The composition and functional state of the mitochondrial oxidative phosphorylation system are informative indicators of organelle bioenergetic capacity. Here, we describe a highly sensitive and reproducible method for a single-cell quantification of mitochondrial CI- and CIV-containing respiratory supercomplexes (CI∗CIV-SCs) as an alternative means of assessing mitochondrial respiratory chain integrity. We apply a proximity ligation assay (PLA) and stain CI∗CIV-SCs in fixed human and mouse brains, tumorigenic cells, induced pluripotent stem cells (iPSCs) and iPSC-derived neural precursor cells (NPCs), and neurons. Spatial visualization of CI∗CIV-SCs enables the detection of mitochondrial lesions in various experimental models, including complex tissues undergoing degenerative processes. We report that comparative assessments of CI∗CIV-SCs facilitate the quantitative profiling of even subtle mitochondrial variations by overcoming the confounding effects that mixed cell populations have on other measurements. Together, our PLA-based analysis of CI∗CIV-SCs is a sensitive and complementary technique for detecting cell-type-specific mitochondrial perturbations in fixed materials.

Identifiants

pubmed: 35474694
doi: 10.1016/j.crmeth.2021.100002
pii: S2667-2375(21)00002-3
pmc: PMC9017192
doi:

Substances chimiques

Electron Transport Complex IV EC 1.9.3.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

100002

Informations de copyright

© 2021 The Authors.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Proc Natl Acad Sci U S A. 2014 Nov 4;111(44):15735-40
pubmed: 25331896
EMBO J. 2020 Jul 15;39(14):e103912
pubmed: 32511785
EMBO Rep. 2018 May;19(5):
pubmed: 29661859
Cell Death Differ. 2018 Mar;25(3):542-572
pubmed: 29229998
Cell Metab. 2008 Apr;7(4):312-20
pubmed: 18396137
Philos Trans R Soc Lond B Biol Sci. 2005 Dec 29;360(1464):2255-8
pubmed: 16321795
Nat Biotechnol. 2002 May;20(5):473-7
pubmed: 11981560
Mol Cell. 2019 Sep 19;75(6):1131-1146.e6
pubmed: 31492636
STAR Protoc. 2020 Jun 03;1(1):100038
pubmed: 33111086
Mol Cell. 2008 Nov 21;32(4):529-39
pubmed: 19026783
Cell Metab. 2014 Dec 2;20(6):1069-75
pubmed: 25470551
Methods Cell Biol. 2020;155:121-156
pubmed: 32183956
Cell. 2008 Jul 11;134(1):112-23
pubmed: 18614015
EMBO J. 2020 Feb 3;39(3):e102817
pubmed: 31912925
J Biol Chem. 2004 Aug 27;279(35):36562-9
pubmed: 15205457
Cell Rep. 2019 May 14;27(7):2212-2228.e7
pubmed: 31091457
Nat Cell Biol. 2018 Jul;20(7):745-754
pubmed: 29950572
EMBO J. 2019 Mar 15;38(6):
pubmed: 30796049
Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10996-1001
pubmed: 20534480
Int J Mol Sci. 2016 Jun 21;17(6):
pubmed: 27338358
PLoS One. 2008 Sep 15;3(9):e3208
pubmed: 18791645
Cell Death Dis. 2015 Jul 09;6:e1814
pubmed: 26158520
J Biol Chem. 2004 Aug 27;279(35):36349-53
pubmed: 15208329
J Biol Chem. 2019 Apr 5;294(14):5386-5395
pubmed: 29233888
EMBO Mol Med. 2016 Mar 31;8(4):311-27
pubmed: 26951622
Nature. 2002 Sep 26;419(6905):367-74
pubmed: 12353028
Mol Metab. 2018 Jul;13:10-23
pubmed: 29780003
Cell Metab. 2017 Feb 7;25(2):301-311
pubmed: 27916530
J Bioenerg Biomembr. 1986 Oct;18(5):331-68
pubmed: 3021714
Hum Mol Genet. 2012 Jan 1;21(1):115-20
pubmed: 21965299
EMBO J. 2000 Apr 17;19(8):1777-83
pubmed: 10775262
Science. 2013 Jun 28;340(6140):1567-70
pubmed: 23812712
Cell. 2016 Dec 1;167(6):1598-1609.e10
pubmed: 27912063
Cell Metab. 2018 Sep 4;28(3):525-531.e4
pubmed: 29937372
Nature. 2016 Nov 24;539(7630):579-582
pubmed: 27775717
EBioMedicine. 2018 Apr;30:29-37
pubmed: 29605508
Antioxid Redox Signal. 2013 Nov 1;19(13):1469-80
pubmed: 23581604
Cell Metab. 2012 Mar 7;15(3):324-35
pubmed: 22342700
Science. 2015 Apr 17;348(6232):340-3
pubmed: 25837514
Am J Physiol Cell Physiol. 2014 Dec 1;307(11):C1017-30
pubmed: 25252946
EMBO Rep. 2020 Dec 3;21(12):e51015
pubmed: 33016568
Cell Death Discov. 2018 Jan 29;4:2
pubmed: 29531799
Ann Neurol. 2016 Feb;79(2):190-203
pubmed: 26506407
EMBO Rep. 2020 Jul 3;21(7):e50287
pubmed: 32496654
Nat Genet. 2018 Dec;50(12):1642-1649
pubmed: 30374071
Nature. 2016 Sep 21;537(7622):639-43
pubmed: 27654917
J Child Neurol. 2014 Sep;29(9):1208-15
pubmed: 25028417
Nucleic Acids Res. 2016 Jan 4;44(D1):D1251-7
pubmed: 26450961
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13063-13068
pubmed: 27799543
Nat Rev Mol Cell Biol. 2003 Jul;4(7):552-65
pubmed: 12838338
J Biol Chem. 2001 Oct 12;276(41):37861-7
pubmed: 11483615
Sci Adv. 2020 Jun 24;6(26):eaba7509
pubmed: 32637615
Nat Rev Dis Primers. 2016 Oct 20;2:16080
pubmed: 27775730
Nature. 2016 Sep 29;537(7622):644-648
pubmed: 27654913
Biochim Biophys Acta. 2012 Jun;1817(6):851-62
pubmed: 21924235
Cell. 2017 Sep 7;170(6):1247-1257.e12
pubmed: 28844695

Auteurs

Fabio Bertan (F)

German Center for Neurodegenerative Diseases (DZNE), Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Venusberg-Campus 1, Gebäude 99, Bonn, North Rhine-Westphalia 53127, Germany.

Lena Wischhof (L)

German Center for Neurodegenerative Diseases (DZNE), Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Venusberg-Campus 1, Gebäude 99, Bonn, North Rhine-Westphalia 53127, Germany.

Enzo Scifo (E)

German Center for Neurodegenerative Diseases (DZNE), Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Venusberg-Campus 1, Gebäude 99, Bonn, North Rhine-Westphalia 53127, Germany.

Mihaela Guranda (M)

German Center for Neurodegenerative Diseases (DZNE), Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Venusberg-Campus 1, Gebäude 99, Bonn, North Rhine-Westphalia 53127, Germany.

Joshua Jackson (J)

German Center for Neurodegenerative Diseases (DZNE), Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Venusberg-Campus 1, Gebäude 99, Bonn, North Rhine-Westphalia 53127, Germany.

Anaïs Marsal-Cots (A)

German Center for Neurodegenerative Diseases (DZNE), Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Venusberg-Campus 1, Gebäude 99, Bonn, North Rhine-Westphalia 53127, Germany.

Antonia Piazzesi (A)

German Center for Neurodegenerative Diseases (DZNE), Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Venusberg-Campus 1, Gebäude 99, Bonn, North Rhine-Westphalia 53127, Germany.

Miriam Stork (M)

German Center for Neurodegenerative Diseases (DZNE), Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Venusberg-Campus 1, Gebäude 99, Bonn, North Rhine-Westphalia 53127, Germany.

Michael Peitz (M)

Institute of Reconstructive Neurobiology, University of Bonn Medical Faculty and University Hospital Bonn, Bonn, North Rhine-Westphalia 53127, Germany.
Cell Programming Core Facility, University of Bonn Medical Faculty, Bonn, North Rhine-Westphalia 53127, Germany.

Jochen Herbert Martin Prehn (JHM)

Royal College of Surgeons in Ireland, Department of Physiology and Medical Physics Department, D02 YN77 Dublin, Ireland.

Dan Ehninger (D)

German Center for Neurodegenerative Diseases (DZNE), Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Venusberg-Campus 1, Gebäude 99, Bonn, North Rhine-Westphalia 53127, Germany.

Pierluigi Nicotera (P)

German Center for Neurodegenerative Diseases (DZNE), Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Venusberg-Campus 1, Gebäude 99, Bonn, North Rhine-Westphalia 53127, Germany.

Daniele Bano (D)

German Center for Neurodegenerative Diseases (DZNE), Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Venusberg-Campus 1, Gebäude 99, Bonn, North Rhine-Westphalia 53127, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH